Echo Biotech completes nearly RMB 100M Series B financing to advance next-generation exosome regenerative therapies and systemic anti-aging solutions

Echo Biotech has completed a nearly RMB 100 million Series B round, led again by Zhongbo Juli with participation from Guosheng Capital, to accelerate development of next-generation exosome regenerative therapies and systemic anti-aging solutions.